Lowered cisplatin dose and no bleomycin in the treatment of pediatric germ cell tumors: Results of the GCT-99 protocol from the brazilian germ cell pediatric oncology cooperative group

Journal of Clinical Oncology

Volumn 34, Issue 6, 2016, Pages 603-610

  Lopes, Luiz Fernando ^a   Macedo, Carla Renata Pacheco Donato ^b   Dos Santos Aguiar, Simone ^j   Barreto, Jose Henrique S ^l   Martins, Gisele Eiras ^a   Sonaglio, Viviane ^c   Milone, Marcelo ^k   Lima, Eduardo Ribeiro ^m   De Assis Almeida, Maria Teresa ^d   Lopes, Paula Maria Azevedo Allemand ^a,n   Watanabe, Flora Mitie ^o   D'Andrea, Maria Lydia Mello ^e   Pianovski, Mara Albonei ^p   Melaragno, Renato ^f   Vianna, Sonia Maria Rossi ^g   Moreira, Mauber Eduardo Schultz ^q   Bruniera, Paula ^h   De Oliveira, Cleyton Zanardo ⁱ  

^a Hospital de Cancer Infanto Juvenil de Barretos   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e Hospital Infantil Darcy Vargas   (Brazil)

^f HOSPITAL SANTA MARCELINA   (Brazil)

^g HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^h Santa Casa de Misericordia de Sao Paulo   (Brazil)

ⁱ BARRETOS CANCER HOSPITAL   (Brazil)

^j CENTRO INFANTIL BOLDRINI   (Brazil)

^k Centro de Tratamento Fabiana Macedo de Morais   (Brazil)

^l HOSPITAL SÃO RAFAEL   (Brazil)

^m Hospital da Baleia   (Brazil)

ⁿ Hospital da Criança José de Alencar   (Brazil)

^o HOSPITAL PEQUENO PRÍNCIPE   (Brazil)

^p Hospital Erasto Gaertner   (Brazil)

^q Hospital Universitario de Santa Maria   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BLEOMYCIN; CHORIONIC GONADOTROPIN; CISPLATIN; CREATININE; ETOPOSIDE; IFOSFAMIDE; LACTATE DEHYDROGENASE; VINBLASTINE; ANTINEOPLASTIC AGENT;

ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; BLOOD TOXICITY; BRAZILIAN; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG RESPONSE; DRUG TREATMENT FAILURE; EVENT FREE SURVIVAL; FEMALE; GERM CELL TUMOR; HEARING IMPAIRMENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH FREQUENCY HEARING LOSS; HIGH RISK PATIENT; HISTOLOGY; HUMAN; INFECTION; INTERMEDIATE RISK PATIENT; KIDNEY TUBULE DISORDER; LACTATE DEHYDROGENASE BLOOD LEVEL; LOW DRUG DOSE; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NEUTROPENIA; OVERALL SURVIVAL; PEDIATRIC SURGERY; PRIORITY JOURNAL; SIDE EFFECT; SPEECH INTELLIGIBILITY; TREATMENT OUTCOME; BRAZIL; DISEASE FREE SURVIVAL; HEAD AND NECK NEOPLASMS; MEDIASTINAL NEOPLASMS; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; PATHOLOGY; RETROPERITONEAL NEOPLASMS; RISK ASSESSMENT; SURVIVAL RATE; TESTICULAR NEOPLASMS; VAGINAL NEOPLASMS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BRAZIL; CHILD; CISPLATIN; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IFOSFAMIDE; MALE; MEDIASTINAL NEOPLASMS; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; RETROPERITONEAL NEOPLASMS; RISK ASSESSMENT; SURVIVAL RATE; TESTICULAR NEOPLASMS; VAGINAL NEOPLASMS; VINBLASTINE;

EID: 84964228881     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.59.1420     Document Type: Article

References (21)

1. Young JL Jr, Ries LG, Silverberg E, et al: Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer 58:598-602, 1986 (suppl 2)
2. Poynter JN, Amatruda JF, Ross JA: Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975 to 2006. Cancer 116:4882-4891, 2010
3. Bosl GJ, Motzer RJ: Testicular germ-cell cancer. N Engl J Med 337:242-253, 1997
4. Einhorn EH: Testicular cancer: An oncological success story. Clin Cancer Res 3:2630-2632, 1997
5. Margolin K, Doroshow JH, Ahn C, et al: Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support. J Clin Oncol 14: 2631-2637, 1996
6. Gö bel U, Schneider DT, Calaminus G, et al: Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. Ann Oncol 11:263-271, 2000
7. Lopes LF, Macedo CR, Pontes EM, et al: Cisplatin and etoposide in childhood germ cell tumor: Brazilian Pediatric Oncology Society protocol GCT-91. J Clin Oncol 27:1297-1303, 2009
8. Lopes LF, Sonaglio V, Ribeiro KC, et al: Improvement in the outcome of children with germ cell tumors. Pediatr Blood Cancer 50:250-253, 2008
9. Lopes LF, De Camargo B, Dondonis M, et al: Response to high-dose cisplatin and etoposide in advanced germ cell tumors in children: Results of the Brazilian Germ Cell Tumor Study. Med Pediatr Oncol 25:396-399, 1995
10. Davidoff AM, Hebra A, Bunin N, et al: Endodermal sinus tumor in children. J Pediatr Surg 31: 1075-1078, 1996; discussion 1078-1079
11. Mostofi FK, Sobin LH: Histological Typing of Testis Tumors. Geneva, Switzerland, World Health Organization, 1933
12. Gonzalez-Crussi F, Winkler RF, Mirkin DL: Sacrococcygeal teratomas in infants and children: Relationship of histology and prognosis in 40 cases. Arch Pathol Lab Med 102:420-425, 1978
13. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
14. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
15. Liberman PHP, Schultz C, Goffi-Gomez MVS, et al: Speech recognition and frequency of hearing loss in patients treated for cancer in childhood. Pediatr Blood Cancer 60:1709-1713, 2013
16. Frazier AL, Rumcheva P, Olson T, et al; Children's Oncology Group: Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: A report from the Children's Oncology Group. Pediatr Blood Cancer 50:746-751, 2008
17. Pizzo A, Poplack D (eds): Biological markers in pediatric cancer, in: Principlesand Practice of Pediatric Oncology. Philadelphia, PA, Lippincott, 1989, pp 149
18. Lo Curto M, D'Angelo P, Cechetto G, et al: Mature and immature teratomas: Results of the first paediatric Italian Study. Pedaitr Surg Int 23:315-322, 2007
19. Baranzelli MC, Kramar A, Bouffet E, et al: Prognostic factors in children with localized malignant nonseminomatous germ cell tumors. J Clin Oncol 17:1212, 1999
20. Mann JR, Raafat F, Robinson K, et al; The United Kingdom Children's Cancer Study Group's second germ cell tumor study: Carboplatin, etoposide, and bleomycin are effective treatment for childrenwith malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol 18:3809-3818, 2000
21. Frazier AL, Hale JP, Rodriguez-Galindo C, et al: REVISED risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States. J Clin Oncol 33:195-201, 2015